Akers Biosciences Inc. | Ownership
Companies that own Akers Biosciences Inc.
The Vanguard Group, Inc.
2,573,338
2.74%
26,096
0%
06/30/2018
Empery Asset Management LP
2,491,591
2.65%
1,766,955
0.82%
12/31/2017
G1 Execution Services LLC
1,605,176
1.71%
1,605,176
0.02%
06/30/2018
BlackRock Fund Advisors
1,315,815
1.4%
1,300,405
0%
06/30/2018
Geode Capital Management LLC
458,458
0.49%
144,459
0%
06/30/2018
Citadel Advisors LLC
296,665
0.32%
-25,985
0%
06/30/2018
Virtu Financial BD LLC
266,886
0.28%
266,886
0%
06/30/2018
Northern Trust Investments, Inc.
154,248
0.16%
0
0%
06/30/2018
Miton Asset Management Ltd.
132,906
0.14%
0
0%
09/29/2017
Bard Associates, Inc.
116,400
0.12%
-5,300
0.01%
06/30/2018
| Address |
201 Grove Road
West Deptford New Jersey 08086
United States
|
|
Employees
|
- |
| Website |
http://www.akersbio.com |
| Updated |
07/08/2019 |
| Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. |
